Abstracts

2022 - Oral communication

Therapeutics-Miscellaneous

Can Doctors Treat Gout Well? Insight On Gout Management In Referral Centres

Charlotte Jauffret, Sebastien Ottaviani, Augustin Latourte, Hang Korng Ea, Sahara Graf, Frederic Lioté, Thomas Bardin, Pascal Richette, Tristan Pascart

2018 - Poster

Therapeutics-Miscellaneous

GOUT AND PARKINSON’S DISEASE IN A MEDITERRANEAN URBAN POPULATION. A CASE-CONTROL STUDY

Francesc Orfila Pernas1,2, Marina Pou Gimenez¹, Cesar Diaz-Torne³, Enrique Calvo Aranda4

2020 - Poster

Therapeutics-Miscellaneous

Key role of the Clinical Nurse Specialist in patients with gout: results of a quality-of-care survey

E. Calvo-Aranda 1, FM. Sanchez-Aranda, L. Cebrian-Mendez, MA. Matias De La Mano, L. Lojo-Oliveira, MT. Navio-Marco

2020 - Poster

Therapeutics-Miscellaneous

HOME-MONITORING GOUT FLARES WITH A SMARTPHONE APP RESULTS OF A FEASIBILITY STUDY

Bph. Pouls 1,2, Cl. Bekker 2, Bjf. Van Den Bemt 1,2, Al. Gaffo 3, M. Flendrie 1

2021 - Oral communication

Therapeutics-Miscellaneous

MICROGLIA CONTROL SMALL VESSEL CALCIFICATION VIA TREM2

Yvette Zarb(1) , Sina Nassiri(2), Sebastian Guido Utz(3), Johanna Schaffenrath(1), Mauro Delorenzi(2), Marco Colonna(4), Melanie Greter(3), Annika Keller(1)

2015 - Poster

Therapeutics-Miscellaneous

Serum magnesium levels in patients in relation to diuretic treatment

Irati Urionagüena, Sandra P. Chinchilla, Fernando Perez-Ruiz.

2021 - Oral communication

Therapeutics-Miscellaneous

A precise identification of crystal deposits in the kidney tissue

Frochot V, Jouanneau C, Letavernier E, Haymann JPh, Bazin D, Daudon M.

2021 - Oral communication

Therapeutics-Miscellaneous

PSEUDOXANTHOMA ELASTICUM (PXE) PATIENTS AND HETEROZYGOUS CARRIERS HAVE DECREASED PLASMA PPI LEVELS WHICH CORRELATE WITH THE CARDIO(VASCULAR) PHENOTYPE.

M. Van Gils [1,2], J. Depauw [1], S. Verschuere [1,2], L. Nollet [1,2], O.M. Vanakker [1,2]

2015 - Poster

Therapeutics-Miscellaneous

How the appearance of tophi changes ultrasonographic parameters independently associated with cardiovascular risk.

R. Gancheva¹, A. Kundurdjiev², M. Ivanova¹, T. Kundurzhiev³, R. Rashkov¹, Z. Kolarov¹

2018 - Poster

Therapeutics-Miscellaneous

Rheopheresis for adjuvant treatment in resistant calciphylaxis

Elise Bouderlique, Arnaud Lionet, François Provot, T. Dekeyser, Jeremy Zaworski, Célia Lessore De Sainte Foy, Christian Noël

2017 - Poster

Therapeutics-Miscellaneous

Cardiovascular risk and endothelial dysfunction in patients with gout. Experience in a spanish multi-hospital group

E. Calvo Aranda, O. Carrion, A. Abdelkader, JJ. Gonzalez-Martin, F. Aramburu, C. Marin, S. Rodriguez Rubio, M . Valero, F. Sainz, P. Garcia de la Peña Lefebvre